Y-mAbs Therapeutics
(NASDAQ:YMAB)
$15.34
00
At close: Jul 1
$15.34
00
After Hours: 4:02PM EDT
Day High/Low- - -
52 Week High/Low6.5 - 39.82
Open / Close- / -
Float / Outstanding36.4M / 43.7M
Vol / Avg.- / 462.2K
Mkt Cap670.6M
P/E-
50d Avg. Price11.37
Div / Yield-
Payout Ratio-
EPS-0.64
Total Float36.4M

Y-mAbs Therapeutics (NASDAQ:YMAB), Quotes and News Summary

Y-mAbs Therapeutics (NASDAQ: YMAB)

Day High/Low- - -
52 Week High/Low6.5 - 39.82
Open / Close- / -
Float / Outstanding36.4M / 43.7M
Vol / Avg.- / 462.2K
Mkt Cap670.6M
P/E-
50d Avg. Price11.37
Div / Yield-
Payout Ratio-
EPS-0.64
Total Float36.4M
Benzinga - Apr 27, 2022, 4:05PM
Benzinga - Apr 8, 2022, 9:01AM
load more
Sector: Health Care.Industry: Biotechnology
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.720-0.640 0.0800
REV10.900M10.486M-414.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Y-mAbs Therapeutics Questions & Answers

Q
How do I buy Y-mAbs Therapeutics (YMAB) stock?
A

You can purchase shares of Y-mAbs Therapeutics (NASDAQ: YMAB) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Y-mAbs Therapeutics's (YMAB) competitors?
Q
What is the target price for Y-mAbs Therapeutics (YMAB) stock?
A

The latest price target for Y-mAbs Therapeutics (NASDAQ: YMAB) was reported by BMO Capital on Friday, June 24, 2022. The analyst firm set a price target for 27.00 expecting YMAB to rise to within 12 months (a possible 76.01% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Y-mAbs Therapeutics (YMAB)?
A

The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $15.34 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Y-mAbs Therapeutics (YMAB) pay a dividend?
A

There are no upcoming dividends for Y-mAbs Therapeutics.

Q
When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?
A

Y-mAbs Therapeutics’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Y-mAbs Therapeutics (YMAB) going to split?
A

There is no upcoming split for Y-mAbs Therapeutics.

Q
What sector and industry does Y-mAbs Therapeutics (YMAB) operate in?
A

Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.